Correction to PV1 downregulation via shRNA inhibits the growth of pancreatic adenocarcinoma xenografts.

Authors:
NA

Journal:
J Cell Mol Med

Publication Year: 2023

DOI:
10.1111/jcmm.17980

PMCID:
PMC10718131

PMID:
37920132

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Cell Mol Med

Abbreviation: J Cell Mol Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Molecular Biology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Adenine base editor-based correction of the cardiac pathogenic Lmna c.1621C > T mutation in murine …
Yang L; Liu Z; Sun J and 3 more (2024) - Transparency Score: 4/6
A systematic review on deep learning-based automated cancer diagnosis models.
Tandon R; Agrawal S; Rathore NPS and 2 more (2024) - Transparency Score: 3/6
Atractylodes macrocephala III suppresses EMT in cervical cancer by regulating IGF2BP3 through ETV5.
Wang M; Meng J; Wang H and 2 more (2024) - Transparency Score: 4/6
Construction of endothelial cell signatures for predicting the diagnosis, prognosis and immunothera…
Fu Y; Sun S; Shi D and 1 more (2024) - Transparency Score: 4/6
C-X-C chemokine receptor type 4 promotes tubular cell senescence and renal fibrosis through β-caten…
Wu Q; Chen Q; Xu D and 12 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
16.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025